Infectious Diseases Pharmacotherapy for Children With Cystic Fibrosis

J Pediatr Health Care. 2015 Nov-Dec;29(6):565-78; quiz 579-80. doi: 10.1016/j.pedhc.2015.07.010.

Abstract

Cystic fibrosis (CF) affects several organs, most notably the lungs, which become predisposed to infections with potentially severe consequences. Because of physiologic changes and infection characteristics, unique approaches to antimicrobial agent selection, dosing, and administration are needed. To provide optimal acute and long-term care, pediatric health care providers must be aware of these patient features and common approaches to antimicrobial therapy in CF, which can differ significantly from those of other infectious diseases. The purpose of this article is to review common respiratory pathogens, pharmacology of commonly used antimicrobial agents, and unique pharmacokinetics and dosing strategies often used when treating children with CF.

Keywords: CF; Cystic Fibrosis ID Pharmacology; Cystic Fibrosis ID Pharmacotherapy.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacokinetics*
  • Child
  • Child, Preschool
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / physiopathology
  • Drug Administration Schedule
  • Humans
  • Practice Guidelines as Topic
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / physiopathology

Substances

  • Anti-Bacterial Agents